ALUR
Allurion Technologies, Inc.
Mentions (24Hr)
0.00% Today
Reddit Posts
Mentions
Out of my positions. Made some on KLTR, lost it and some more on ALUR. Two weeks made myself note to cautious about small biotechs. Am changing that to a rule - never buy small biotechs for a day trade!
Looking to either get into VIVK or ALUR tomorrow
Looks like on ALUR the market is right now focusing more on the dilution and less on the debt-free part.
$ALUR - news and tiny float? 
Wonder what $ALUR will do on market open, tiny float
ALUR got some positive news and has a tiny float - might go wild
Anyone in on $ALUR for tomorrow?
Seems like ALUR was a flop lol… gonna wait to see what open brings
Throwing some into ALUR to hold overnight. News was pretty good and float is small too! 🤞
Thanks for giving an early call, I will stay on IXHL, but I will put some money in ALUR if I can tomorrow.
Hope yall made some money on my calls from last night! (ALUR, SRXH, YHC) A broken clock is right twice a day!
ALUR recovering for now
Who else is in NCNA HWH BLUE and ALUR
Made money on both SRXH and ALUR although not much on ALUR
Agreed, I'm just looking for next-day plays when I screen. There are usually plenty others to keep me busy rather than holding out, but this is on my watchlist. I called the PM pump on SRXH and the PM dip on ALUR last night and made money on both. These multi-day/week holds I get too distracted on and usually miss them lol.
Looks like ALUR corrected down as predicted, then pumped after a double bottom. Wish I got up just a lil earlier 🤣
ALUR Popped up to already https://preview.redd.it/0mcoc051ho0f1.jpeg?width=1290&format=pjpg&auto=webp&s=e389340369159ab8b34dfd1925433668b9a3c47f
Will be watching these tomorrow, but by no means are they the best picks. I'll rescan in the morning. **SMTK** just released ER, not great, but will be presenting alleged new tech tomorrow at SID Business Conference. **YHC** offering tanked it some, which may be why they released their ER early. Not seeing any reporting on ER, only the filing, even though it was decent. Will watch. **SRXH** ER on the 15th post market, looks like it already corrected after the double bottom. **ALUR** ran today on good news, but just had theirshelf offering approved of up to $300m so may correct down, premarket earnings release tomorrow
Yeah? The guy wasn’t talking just about SPGC though, and I’ve had worse losses than SPGC that I’m holding (ALUR, MGOL/HMR). What’s with all the SPGC hate lmao
Baby breh* im the one who brought this group ALUR, just saying my plays for tomorrow that I think will be good ! Simple
Been on a rough run since ALUR, need some guidance for tomorrow I’ve seen MGOL but what’s the catalyst there ? SPGC a bit of a risk it seems unless it dips a lot
Bought today at .43 , offering at $1.40 closes tmrw 200 million projected revenue over next 5 years , only way us up, way up. Check back with me in a few days or buy tonight and thank me, (Called ALUR last week)
Cash per share a dollar , 200 million dollar contract , offering at $1.40 this week , this will easily hit over $1 next day or two , this one will be better than ALUR imo
Dude I jumped on your ALUR train before. Why do you think STSS. I don’t see any good news and it’s been taking past week. I’m so down to follow you
Well it's not that hard to identify stocks poised to go up, just this past few weeks i made money off ALUR, HWH, HEPA, BMRA, etc. And before you say "oh yeah you bought on the way up" only one there i bought over 15 percent up was ALUR. if you think the stocks going to fail don't buy it i made it pretty clear it's speculative off insider buying and the fact it's had flatlined price movement and volume the past 3 months. Lots of videos on youtube to help you find potential winners and the flags to look for that they will go up. Just because you struggle to catch winners before they go up doesn't mean everyone else does.
People hated when I also called ALUR last week!
I'm in LUCD. I am convinced it of the EsoGuards effectiveness and potential to disrupt the market for detecting Esohphogeal cancer. Willing to ride the dips. I'm also tryimg to diversify into other biotech/medical stocks poised for gains an am considering: MCRB, LXRX, ALUR and ICAD.
#**TLDR** --- **Ticker:** ALUR **Direction:** Up (Short Term) **Prognosis:** Buy now, dump after FDA AUDACITY trial readout. **Expected Catalyst:** FDA AUDACITY trial readout for Allurion Balloon (weight loss device) expected before year-end. **Author's Play:** Pump and dump. Long on calls and common, selling after expected spike. **Long-Term Outlook:** Bearish due to debt, operational issues, and likely dilution. Suggests eventual acquisition by a larger pharma company.
Yeah, this might be the case even with o1. I asked 4o, which has internet access, and it gave these: 1. Allurion Technologies (ALUR): Specializes in weight loss platforms, including a swallowable, procedure-less intragastric balloon. Analysts have given it a 'Buy' rating with a consensus price target of $2.88, suggesting significant upside potential. 2. Cresco Labs (CRLBF): A U.S.-based cannabis company offering a range of products under various brands. It holds a 'Moderate Buy' rating with a consensus price target of $2.50, indicating potential growth. 3. Ocugen (OCGN): A clinical-stage biopharmaceutical company focusing on gene and cell therapies. It has a 'Buy' rating with a consensus price target of $5.67, reflecting optimism about its pipeline. 4. American Lithium Corp (LI): Based in Vancouver, this company has significant lithium projects in the Americas, essential for rechargeable batteries. The TLC lithium project in Nevada has an estimated net present value of $3.26 billion. 5. BlackBerry Limited (BB.TO): Formerly a smartphone leader, BlackBerry now focuses on cybersecurity and the Internet of Things. Recent restructuring has led to cost savings, aiming for near-term profitability. 6. Tilray Brands Inc (TLRY.TO): A prominent cannabis company with international operations, including cannabis-infused beverages. Its beverage division reported over $300 million in pro forma revenue in 2023. 7. FOBI AI (FOBI.V): A data analytics company utilizing AI and IoT to enhance business efficiency. Clients include Shopify and Lightspeed, with technology used in over 150 countries in 2023. 8. Good Natured Products (GDNP): Focuses on eco-friendly products, aligning with increasing consumer demand for sustainable options. 9. Advantage Oil and Gas Ltd. (AAV): A Canadian oil and gas company with a strong profit margin, poised to benefit from rising oil prices. 10. Sportsman's Warehouse (SPWH): An outdoor sporting goods retailer showing same-store sales growth and a low P/E ratio, indicating potential undervaluation.
ALUR. New player in the weight loss game
ALUR gang oyybrent? Some good news
Don't think ALUR is a drug, [it's a weight loss balloon](https://www.allurion.com/en). Takes up space in the stomach to make the person feel full faster. Makes sense that walking a lot plus eating less might lead to those results.
$ALUR April 19 $2.5 puts 👀
$ALUR April 19 $2.5 puts 🪦
WTF is $ALUR and why is it over 100% today?
$ALUR up over 100% on 100x average daily volume (22M shares). Almost New 90day high. But only now trading where it was 90 days ago. ($3.60 ish) No news or filings that I can see. Warrants also up, not as much percentage-wise, volume or price (10x, 60%)
ALUR is a company that makes gastric balloons for fat asses, perhaps we see a balloon spike
When will buy ALUR for a couple billion? Allurion - Weight Loss Treatment - Not an injection Basically they put a balloon in your stomach that takes up space for ye ole fat bastards so they feel full quicker It’s an obesity treatment and not specific to diabetes
yes, you would. similar ratio on $CPUH->$ALUR, which I was short on
An interesting quote from Allurion's (ALUR) earnings call a couple of weeks ago was CFO Chris Geberth stating: *"Revenue for the year-to-date period ended September 30, 2023 was $45.2 million, essentially even for the same period of 2022.* ***As the business combination closed later than planned****, we delayed sales and marketing initiatives during the year."* Allurion guided to $100M revenue for 2023 in their [investor presentation](https://www.sec.gov/Archives/edgar/data/1828608/000121390023009565/ea172635ex99-2_compute.htm) which would be more than a 50% YoY increase. Obviously they aren't getting anywhere near that. The CFO seems to blame a delayed business combination for the lack of revenue growth. Allurion announced their business combination with CPUH on February 9 2023 and completed on August 1 which is less than a 6 month turnaround. According to [this article](https://www.skadden.com/-/media/files/publications/2023/06/de_spac_transaction_trends_in_2023.pdf) the average time from signing to closing a SPAC transaction was 5.2 months in 2021 and 6.8 months in 2022. I don't have data for 2023 but a quick glance shows most deals have taken more than 6 months from DA to closing (some more than a year) so I'd assume the average would be higher than 2022. Seems a bit scummy to blame a delayed business combination for lack of revenue when you were actually one of the quicker deals of the year to get through.
deSPAC ALUR doing well and heading towards its $7 initial price pretty quickly after the ticker change drop off, with warrants at $1 today.
Same, med tech and SaaS are generally where I stay and ALUR has been well regarded as far as product/recognition. I think $7-$8 is probably current fair value, and could definitely end up multiples higher, but med device companies can be fickle until they have some scale. Braver me would have held.
Congrats! I managed to snipe the ALUR bottom as well. The drop was puzzling so I blindly bought the high 2s.
Not that anyone cares, but I’ve been getting really lucky with timing the last month or so. Sold DOCN before earnings. Sold off ZS after earnings and rolled it in to PATH which has had a nice earnings bump. Took a small ALUR position and sold 60% up. Pretty much killed off warrantfolio with minimal losses and moved a big chunk to SKIN last week/yesterday. Biggest mistake was selling THRN on initial deal rumor which left 60% on the table, and buying MRVI before their earnings (~20% tax harvest). Did also lose ~20% on ORGN too, but only had 100 shares to keep an eye on so not much $. What moves are you all making/watching?
You’re confusing ALUR I think ALLG was SPAQ
Wasn’t there a big ALUR poster, it seems interesting here, is there a target for US approval?
Was there some news regarding ALUR? oof at that common drop.
Planned on holding the ALUR shares through clinical trials/US approval but it still hurts to look at.
ALUR will become a penny stock... I think it will bounce back after 0.3 $
ALUR options are so wonky... seems to be sellers selling deep ITM puts at much less than their intrinsic value